key: cord-0260394-g3bxxwzj
authors: Kumar, Ashutosh; Narayan, Ravi K.; Kumar, Sujeet; Pareek, Vikas; Kumari, Chiman; Jha, Rakesh K.; Prasoon, Pranav
title: NRP1 and furin as putative mediators of SARS-CoV-2 entry into human brain cells
date: 2022-01-20
journal: bioRxiv
DOI: 10.1101/2022.01.19.476893
sha: 99b280c00d07d57cb847bce7d8652482bf6de124
doc_id: 260394
cord_uid: g3bxxwzj

COVID-19 has prominent neurological manifestations including psychiatric symptoms, indicating significant synaptic pathology. Surprisingly, existing evidence suggests negligible expression of the key SARS-CoV-2 host cell entry mediators ACE2 and TMPRSS2 in human brain, which complicates understanding of the pathomechanisms of the neuropsychiatric manifestations in COVID-19. Recent studies suggested that an alternative host-cell entry receptor, NRP1, can mediate entry of furin cleaved SARS-CoV-2 spike proteins into the host cells. However, the role of NRP1 and furin in mediating SARS-CoV-2 entry in human brain cells has been least explored and remains a lacuna in the literature. We performed an in silico analysis of the transcriptomic and proteomic expressions of SARS-CoV-2 host-cell entry receptors and associated tissue proteases in human brain tissue, using the publically available databases. Based on the expression analysis, SARS-CoV-2 entry in human brain cells is likely to be mediated through NRP1 and furin. Graphical Abstract

COVID-19 has prominent neurological manifestations as the acute and long term sequelae, including psychiatric symptoms 1, 2 . Psychiatric manifestations primarily have indicated significant synaptic pathology. SARS-CoV-2, the viral agent of COVID-19 is known to enter host-cells through a cell surface receptor, ACE2-angiotensin converting enzyme 2 3 . Along with ACE2, the cellular expressions of host-proteases such as TMPRSS2 and furin, which cleave the viral spike protein are considered essential for SARS-CoV-2 infection 3 . SARS-CoV spike (S) protein uniquely contains a polybasic sequence motif, Arg-Arg-Ala-Arg (RRAR), at the S1/S2 boundary (682-685 aa). It provides a cleavage site for the host serine protease, furin. Inclusion of the furin cleavage site (FCS) is said to be an evolutionary gain in SARS-CoV-2 considering its conspicuous absence in other related SARS viruses, including SARS-CoV-1 3 , and has been shown to increase infectivity and tissue tropism. The emerging SARS-CoV-2 variants have accumulated mutations at the FCS potentially favoring a furin mediated processing 4 . The C-terminus of the S1 protein generated by furin cleavage confirms to a [R/K]XX[R/K] motif, termed the "C-end rule" that can potentially bind to neuropilin receptors expressed on the host cells, and comprises of a set of host peptides known to be involved in pleiotropic physiological/pathological activities, such as axonal guidance, angiogenesis and vascular permeability, immune regulation, and survival of cancer cells. Recent studies suggested that neuropilin-1 (NRP1) can bind to furin cleaved SARS-CoV-2 spike protein and facilitate ACE2 mediated SARS-CoV-2 entry into host cells 5 . In addition, in higher viral titers, NRP1 can independently mediate viral entry of into the host cells 5, 6 . Notably, blocking the NRP1-spike protein interaction by RNA interference or selective inhibitors reduced SARS-CoV-2 entry and infectivity in cell culture 5, 6 .

Currently, the pathomechanisms of neuropsychiatric manifestations in COVID-19 remains least understood. Among diverse contenders, a receptor based mediation of SARS-CoV-2 entry in human brain, either through olfactory or vagal nerves, or neurovascular routes remains a plausible mechanism 7 . However, the role of ACE2 in mediating SARS-CoV-2 entry into brain cells appears less plausible as existing evidence suggests that there is negligible ACE2 expression in human brain tissue 7 . There is therefore, a need to look for alternative cell-receptor, which can mediate SARS-CoV-2 entry in human brain in scarce presence of ACE2. Finding the key mediators of SARS-CoV-2 entry into the brain cells remains a lacuna in the literature. Multiple authors have suggested for a NRP1 mediated mechanism behind neuropsychiatric symptoms in COVID-19 since identification of the NRP1 as an alternative SARS-CoV-2 entry receptor in human cells (6, 7) . However, the studies are lacking which have studied relative distributions for the SARS-CoV-2 entry mediators and entry associated molecules in the human brain. In this study, we performed an in silico analysis of the publically available databases providing transcriptomic and proteomic expressions of ACE2 and TMPRSS2, and NRP1 and furin in human brain regions with an aim to know whether the later may have an edge in mediating COVID-19 neuropathology.

Pathogenesis of the neuropsychiatric manifestations in COVID-19 remains little understood in absence of the precise knowledge about the molecular mediators of SARS-CoV-2 entry into the brain cells. Finding the key mediators of SARS-CoV-2 entry into the brain cells may help develop targetbased therapeutic strategies and suitable drug targets for treating neuro-COVID. Our study unravels relative expressions of SARS-CoV-2 host cell-entry receptors ACE2 and NRP1 and entry-associated host proteases TMPRSS2 and furin in human brain regions providing important insights regarding the viral entry into the brain-cells and consequent neuropathology. ACE2 and TMPRSS2 were notdetected in transcriptomic (NX < 1) and proteomic expression analysis in any of the human brain regions, including hippocampal formation (Figs. 1a, 2). (Figs. 1b, 2) . The protein expressions of NRP1 and furin were detectable in neuronal cell, neuropil, and glial cells of the brain tissue (Fig. 3) . Based on the expression analysis of the SARS-CoV-2 entry-receptors and the entry-associated hostproteases in the human brain tissues, SARS-CoV-2 entry into human brain cells is likely to be mediated independently through NRP1 and furin, instead of ACE2 and TMPRSS2. The significant expression of NRP1 and furin in neuronal cells, including within the olfactory epithelium and hippocampal formation, suggests that NRP1 may have a role in the pathomechanisms of synaptic pathologies; such as, loss of the sense of smell and taste, memory loss, and multiple psychiatric manifestations in COVID-19, as the acute or long term sequelae. Notably, NRP1 also has a known role in the regeneration and plasticity of adult neurons 9 . It works as a receptors for Semaphorin 3Aan axonal guidance protein 9 , and vascular endothelial growth factor A (VEGF-A) 10 -a key molecule involved in hippocampal neurogenesis. A recent study has shown that the SARS-CoV-2 spike protein binding to NRP1 in sensory nerves can induce analgesia by altering VEGF-A mediated neuronal signaling 10 . Of note, the olfactory epithelium and the hippocampus are the known sites for the ongoing neurogenesis in the adult humans and interestingly, both of these brain regions are also implicated in COVID-19 neuropathology. A SARS-CoV-2 infection induced disruption of the ongoing olfactory and hippocampal neurogenesis and/or plasticity in COVID-19 patients remains a plausibility in view of high NRP1 and furin expression in these brain regions. A disrupted neurogenesis can also explain frequent olfactory and hippocampal dysfunctions in COVID-19 cases 11, 12 . Furthermore, the SARS-CoV-2 induced neuro-immune dysfunction and neuro-inflammation can be also mediated through NRP, given its known role as an immune checkpoint of T cell memory and inflammation 13 .

In conclusion, our study provides important lead for conducting in vivo studies considering the NRP1 and furin, as the putative mediators of SARS-CoV-2 entry into the brain-cells.

For certain brain regions proteomic expression data were not available to corroborate transcriptomic expressions of the studied markers. Further, the study didn't employ any experimental evidence to corroborate the findings derived from the in silico analysis. The in situ/in vivo studies are warranted to validate our findings.

We performed in silico analysis of mRNA and protein expressions of ACE2, NRP1, TMPRSS2, and furin in human brain immune components using the tissue transcriptome and immunohistochemistry (IHC) data available in Human Brain Atlas (HBA), a sub-section of Human Protein Atlas (HPA) (https://www.proteinatlas.org/).

Estimation of mRNA expression and localization of human proteins were performed by the source laboratory using deep sequencing of RNA (RNA-seq) and IHC in normal tissue.

The specimens containing normal-tissue were collected in accordance with approval from the local ethics committee. The specimens were derived from surgically removed tissue, normal was defined by tissue-specific morphological parameters and absence of neoplasia. Antibodies against human ACE2 (HPA000288, CAB026174), NRP1 (HPA030278, CAB004511), TMPRSS2 (HPA035787), and furin (CAB009499) were used. IHC staining was performed on normal tissue microarray using a standard protocol (https://www.proteinatlas.org/download/IHC_protocol.pdf). Protein expression score (low, medium, and high) for each protein was calculated based on the staining intensity (negative, weak, moderate or strong) and fraction of stained cells (<25%, 25-75% or >75%).

The transcriptomic data was collected from the three databases (HPA, GTEx and FANTOM5). For 

We analyzed HPA transcriptomic and proteomic data in respect of tissue specific expression of the screened proteins in human brain components. For each protein, we matched the IHC staining profile with mRNA expression data to yield an 'annotated protein expression' profile. Graphs were plotted and inferences were made based on the final results.

6-Month Neurological and Psychiatric Outcomes in 236 379 Survivors of COVID-19: A Retrospective Cohort Study Using Electronic Health Records

Emerging SARS-CoV-2 Variants Can Potentially Break Set Epidemiological Barriers in COVID-19

Simons, M. Neuropilin-1 Facilitates SARS-CoV-2 Cell Entry and Infectivity. Science

Possible Routes of SARS-CoV-2 Invasion in Brain: In Context of Neurological Symptoms in COVID-19 Patients

Neuropilin-1 as a New Potential SARS-CoV-2 Infection Mediator Implicated in the Neurologic Features and Central Nervous System Involvement of COVID-19

Semaphorin-Neuropilin-1 Interactions in Plasticity and Regeneration of Adult Neurons

SARS-CoV-2 Spike Protein Co-Opts VEGF-A/Neuropilin-1 Receptor Signaling to Induce Analgesia

COVID-19 and Parkinson's Disease: Defects in Neurogenesis as the Potential Cause of Olfactory System Impairments and Anosmia

Neuropilin-1 Is a T Cell Memory Checkpoint Limiting Long-Term Antitumor Immunity

The authors declare no competing interests.